Literature DB >> 28534054

The presence of zinc in the mouse ovary vitrification medium: histological evaluation and follicle growth.

S Geravandi1, M Azadbakht2.   

Abstract

BACKGROUND: Cryopreservation of ovary is a relevant option for preserving fertility of cancer patients undergoing chemotherapy.
OBJECTIVE: To evaluate the effect of zinc in the vitrification medium on histology and follicle growth.
MATERIALS AND METHODS: Mouse ovaries were vitrified in vitrification medium supplemented with 0, 100, 150 or 200 μg/dl zinc, identified as V0, V1, V2 and V3 groups, respectively. Histological evaluation of ovaries was carried out. The isolated pre-antral follicles were cultured. The size and growth of follicles were assessed.
RESULTS: The percentage of morphologically normal follicles increased with increasing zinc concentration in the vitrification medium (P < 0.05). Follicle viability was higher in the V3 than V0 group at the beginning and end of culture (P < 0.05). The highest follicle diameter was obtained in the V3 group after 6 days of culture (P < 0.05).
CONCLUSION: Supplementation of the vitrification medium with zinc can improve follicle viability and growth.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28534054

Source DB:  PubMed          Journal:  Cryo Letters        ISSN: 0143-2044            Impact factor:   1.066


  2 in total

1.  Impact of trace mineral source on beef replacement heifer growth, reproductive development, and biomarkers of maternal recognition of pregnancy and embryo survival.

Authors:  George A Perry; Stephanie D Perkins; Emmalee J Northrop; Jerica J J Rich; Kaitlin M Epperson; Taylor N Andrews; Adalaide C Kline; Lacey K Quail; Julie A Walker; Cody L Wright; Jason R Russell
Journal:  J Anim Sci       Date:  2021-07-01       Impact factor: 3.159

2.  Three-dimensional culture of endometrial cells from domestic cats: A new in vitro platform for assessing plastic toxicity.

Authors:  Morgan Dundon; Odile Madden; Pierre Comizzoli
Journal:  PLoS One       Date:  2019-05-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.